These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2086909)

  • 41. [Application of blood insulin determination in diagnosis of diabetes mellitus and its theoretical basis].
    Kosaka K; Kajinuma H; Sando H; Hagura R
    Nihon Rinsho; 1973 Jul; 31(7):2218-26. PubMed ID: 4582288
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnostic characteristics of the CA-50 and CA 72-4 tumor markers in body fluids. Use in the diagnosis of malignant effusions].
    Lemberger J; Libman E; Lászlo-Klein M; Skenderović S; Novak A
    Med Pregl; 1991; 44(3-4):126-9. PubMed ID: 1921859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
    Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
    Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status.
    D'Adamo PJ; Kelly GS
    Altern Med Rev; 2001 Aug; 6(4):390-405. PubMed ID: 11578255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K; Mitsuhashi F; Ohkura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract]   [Full Text] [Related]  

  • 46. [Control of diabetes and diabetic retinopathy].
    Kojima K; Okajima T; Suzuki M
    Nihon Ganka Kiyo; 1966 Apr; 17(4):470-7. PubMed ID: 6006512
    [No Abstract]   [Full Text] [Related]  

  • 47. [CA-125 values in fluid and serum in females with cystic ovarian tumors].
    Sautter T; Mickan H
    Gynakol Rundsch; 1990; 30 Suppl 1():208-9. PubMed ID: 2079272
    [No Abstract]   [Full Text] [Related]  

  • 48. Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker.
    Benhamou PY; Vuillez JP; Halimi S; Meffre G; Bachelot I
    Diabete Metab; 1991; 17(1):39-43. PubMed ID: 1907932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on diabetic retinopathy. Blood sugar level and total serum cholesterol level].
    Suzuki R
    Nihon Ganka Kiyo; 1966 Apr; 17(4):460-1. PubMed ID: 6006510
    [No Abstract]   [Full Text] [Related]  

  • 50. Changes in the CA 19-9 antigen and Lewis blood group with pulmonary disease severity in cystic fibrosis.
    Kane RE; Penny J; Walker K; Rubin BK; Wu J
    Pediatr Pulmonol; 1992 Apr; 12(4):221-6. PubMed ID: 1614747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diabetic retinopathy and blood sugar levels].
    Kojima K; Suzuki M; Hiramitsu T; Hayakawa K
    Nihon Ganka Kiyo; 1966 Apr; 17(4):449-59. PubMed ID: 6006509
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum levels of CA 19-9 and CA 50 in relation to Lewis blood cell status in patients with malignant and benign pancreatic disease.
    von Rosen A; Linder S; Harmenberg U; Pegert S
    Pancreas; 1993 Mar; 8(2):160-5. PubMed ID: 8460090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Significance of glycolipid analysis in clinical tests].
    Senba U; Okabe H
    Nihon Rinsho; 1989 Dec; 48 Suppl():529-33. PubMed ID: 2516152
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical significance of blood superoxide dismutase analysis in the diagnosis of diabetes mellitus].
    Takano K; Matsuda T; Yanagawa A; Nakagawa T
    Nihon Rinsho; 1990 Dec; 48 Suppl():412-7. PubMed ID: 2086916
    [No Abstract]   [Full Text] [Related]  

  • 55. [Correlation between the levels of CA19-9 and fasting plasma glucose in a case of diabetes mellitus].
    Nakahara Y; Nakahara Y; Matsuyama E; Tamura T
    Nihon Naika Gakkai Zasshi; 1988 Sep; 77(9):1458-9. PubMed ID: 3149970
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical significance of periflux blood flowmeter in diabetes clinic].
    Baba S; Hatanaka H
    Nihon Rinsho; 1990 Dec; 48 Suppl():572-9. PubMed ID: 2086936
    [No Abstract]   [Full Text] [Related]  

  • 57. The sialosyl Lewis a ganglioside is present in tumorigenic human urothelial cell lines.
    Ugorski M; Påhlsson P; Dus D; Nilsson B; Skouv J; Radzikowski C
    Int J Cancer; 1990 Jun; 45(6):1204-9. PubMed ID: 2190940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevation of serum CA 19-9 in parallel with HbA1c in a diabetic female with the Lewis(a+b-) blood group.
    Aoki Y; Yanagisawa Y; Ohfusa H; Kawa S; Oguchi H; Furuta S
    Diabetes Res Clin Pract; 1991 Aug; 13(1-2):77-81. PubMed ID: 1773717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of isoferritin assay as a tumor marker].
    Asakawa H; Yamaguchi K; Mori W
    Nihon Rinsho; 1990 Feb; 48 Suppl():891-4. PubMed ID: 2192172
    [No Abstract]   [Full Text] [Related]  

  • 60. Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group.
    Petit JM; Vaillant G; Olsson NO; Guignier F; Collignon S; Verges B; Brun JM
    Gastroenterol Clin Biol; 1994; 18(1):17-20. PubMed ID: 8187985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.